Day 2 of updates from the annual HD Therapeutics Conference in Palm Springs
Day 1 of updates from the annual HD Therapeutics Conference in Palm Springs
HD drug changes DNA folding across generations
Weighing the scales on mTORC1: A possible new target for HD therapeutics?
A clinical trial for an exciting therapy against HD is planned for 2015. The first step is to make sure it is safe.
The largest ever HD drug trial, testing coenzyme Q10, is halted for 'futility'. What does that mean for HD research?
Does a specific amino acid deficiency contribute to the development of HD?
Raptor Pharmaceuticals announces intermediate results from a long-term study of cysteamine in Huntington's disease
HDBuzz reports from the opening day of science sessions at the 2014 HD Therapeutics Conference in Palm Springs.